v3.26.1
EQUITY-BASED COMPENSATION EXPENSE (Tables)
 3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options Roll Forward
The following table summarizes stock option activity during the three months ended March 31, 2026:
Options Outstanding
(in thousands, except per share amounts)Number of OptionsWeighted-Average Exercise Price
Weighted-Average Remaining Contractual Life
(years)
Aggregate Intrinsic Value(1)
Outstanding, December 31, 2025
12,447$0.71 1.6$3,470 
Granted2001.25 
Exercised(65)0.35 $18 
Forfeited(283)0.38 
Expired(43)2.17 
Outstanding, March 31, 2026
12,256$0.72 1.4$1,160 
Exercisable at March 31, 2026
6,237$1.05 1.5$419 
(1)Based on the amount by which the closing market price of our Class A common stock exceeds the exercise price on each date indicated.
Schedule of Unvested Restricted Stock Units Roll Forward
The following table summarizes the RSU activity during the three months ended March 31, 2026:
Number of Shares
(in thousands)
Weighted-Average Grant Date Fair Value per Share
Unvested, December 31, 2025
2,420 $1.09 
Vested(1)
(816)1.16 
Forfeited(143)1.16 
Unvested, March 31, 2026
1,461 $1.04 
(1)Includes 273 vested shares that were withheld to cover tax obligations and were subsequently cancelled.
Schedule of Equity-Based Compensation Expense
The following table details the equity-based compensation expense by type of award for the periods presented:
Three Months Ended
March 31,
(in thousands)20262025
RSUs
$255 $599 
Stock Options195 29 
Total equity-based compensation expense$450 $628